B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - Journal of Experimental …, 2020 - rupress.org
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - Journal of Experimental …, 2020 - cir.nii.ac.jp
抄録< jats: p> Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - Journal of Experimental …, 2021 - hal.science
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

[PDF][PDF] B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - J. Exp …, 2020 - pdfs.semanticscholar.org
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

[HTML][HTML] Cancer Focus: B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

[HTML][HTML] B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - Journal of Experimental …, 2021 - rupress.org
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - The Journal of …, 2021 - europepmc.org
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan… - Journal of …, 2021 - hal.sorbonne-universite.fr
Whereas T cells have been considered the major immune cells of the tumor
microenvironment able to induce tumor regression and control cancer clinical outcome, a …

[PDF][PDF] B cells and cancer: To B or not to B?

WH Fridman, F Petitprez, M Meylan, T Wei-Wu… - hal.sorbonne-universite.fr
Tertiary Lymphoid Structures, adjacent to tumor nests, are sites where anti-tumor adaptive T
and B cell immune responses are generated. Fridman et al highlight the impact of B cells …